Orlistat for the Treatment of Type I Hyperlipoproteinemia

NCT02767531 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Hyperlipoproteinemia Type I
Hypertriglyceridemia

Interventions

DRUG: Orlistat

Sponsor

University of Texas Southwestern Medical Center